'LIFEView' for End-Stage Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
End-Stage Disease+3 More'LIFEView' - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is looking at whether the audio-video technology 'LIFEView' can help improve wellbeing for people receiving palliative care. The software is loaded onto a laptop and connected to a TV, so it can be used by people who may be disoriented or have reduced physical mobility.

Eligible Conditions
  • End-Stage Disease
  • Quality of Life
  • Psychological Distress
  • Palliative Care

Treatment Effectiveness

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: At least 24 hours before using 'LIFEView', and directly after using 'LIFEView' (pre- and post-'LIFEView')

Hour 48
Change in quality of life measured by the McGill Quality of Life-Revised questionnaire (Cohen et al., 2017)
Hour 48
Change in psychological and physical symptoms measured by the Edmonton Symptom Assessment System-revised (ESAS-r) (Bruera et al., 1991; Watanabe et al., 2011)
Hour 24
Change in blood pressure
Change in heart rate
From initiation of the 'LIFEView' session and directly after using 'LIFEView' (during and post-'LIFEView')
Aspects of participant's level of general well-being as per the Greater Cincinnati Chapter Well-Being Observation tool (Rentz, 2002; Kinney & Rentz, 2005) during the 'LIFEView' session, and other observable phenomena
Hour 24
Psychosocial effects and aspects of quality of life as determined by semi-structured interviews for consenting participants and their consenting family member(s) or caregiver(s).

Trial Safety

Trial Design

1 Treatment Group

'LIFEView' intervention
1 of 1

Experimental Treatment

92 Total Participants · 1 Treatment Group

Primary Treatment: 'LIFEView' · No Placebo Group · N/A

'LIFEView' intervention
Other
Experimental Group · 1 Intervention: 'LIFEView' · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at least 24 hours before using 'lifeview', and directly after using 'lifeview' (pre- and post-'lifeview')

Who is running the clinical trial?

Bruyere Research InstituteLead Sponsor
29 Previous Clinical Trials
2,019,913 Total Patients Enrolled
Bruyere Continuing CareUNKNOWN
Jill Rice, MD, CCFP(PC)Principal InvestigatorBruyère Continuing Care
Rebekah HackbuschPrincipal InvestigatorBruyère Continuing Care

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References